Key result
HAART exposure in perinatally HIV-infected children is linked to a ~1.1 higher LV fractional shortening Z-score.
Why the study?
Does exposure to highly active antiretroviral therapy (HAART) improve long-term echocardiographic measures of left ventricular structure and function in perinatally HIV-infected children compared to HAART-unexposed historical controls?
Cohort (n=214)
Single-blind (centralized echocardiographic interpretation by an independent, blinded cardiologist)
Yes
Does exposure to highly active antiretroviral therapy (HAART) improve long-term echocardiographic measures of left ventricular structure and function in perinatally HIV-infected children compared to HAART-unexposed historical controls?
Answers are grounded in this paper and cite their sources.
Longitudinal follow-up demonstrates that HAART exposure in perinatally HIV-infected children is cardioprotective compared to the pre-HAART era, though a gradual decline in LV contractility over 11 years warrants ongoing cardiovascular surveillance into adulthood.
Background Before the introduction of highly active antiretroviral therapy (HAART), cardiac mortality and morbidity were common in HIV-infected children. Objective To identify long-term cardiovascular effects of HAART in HIV-infected children. Methods The HAART Associated Cardiotoxicity in HIV-Infected Children (CHAART-2) study prospectively compared 148 echocardiograms from 74 HAART-exposed children to 860 echocardiograms from 140 HAART-unexposed but HIV-infected children from the Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) study. Both studies used similar protocol, centralized echocardiographic interpretation and measures expressed as Z-scores referenced to healthy controls. Associations between HAART exposure and echocardiographic measures were evaluated using generalized estimating equations. Results Comparing the HAART exposed and HAART unexposed groups, any HAART exposure was positively associated with left ventricular (LV) fractional shortening (Z-score for difference = 1.07; p = 0.02) and HAART exposure duration (Z-score difference per year = 0.17; p = 0.003. LV mass was negatively associated with any HAART exposure (Z-score difference = −0.64; p = 0.01) as was septal thickness (Z-score difference = −0.93; p = 0.001). Duration of HAART exposure was negatively associated with LV end-systolic dimension and heart rate (Z-score difference per year= −0.11; p = 0.05 and Z-score difference per year= −0.10; p = 0.002, respectively). During 11 years of follow-up, in the HAART-exposed group, LV mass and LV end-diastolic septal thickness were lower while LV contractility and LV fractional shortening were higher when compared to the HAART-unexposed group. Conclusions Cardiac structure and function were better in perinatally HIV-infected children exposed to HAART than in those of similar children from the pre-HAART era but did decline over time. Evidence-based strategies for cardiovascular monitoring are needed to inform treatment decisions to improve long-term cardiovascular health.
No takes yet. Share an insight, caveat, or question.
Lipshultz et al. (2017) conducted a cohort in Perinatally HIV-infected children (n=214). Highly active antiretroviral therapy (HAART) / combination antiretroviral therapy vs. HAART-unexposed historical controls from the pre-HAART era (91% exposed to zidovudine monotherapy, 9% ART-unexposed) was evaluated on Left ventricular (LV) fractional shortening Z-score (MD 1.07 Z-score, p=0.02). Highly active antiretroviral therapy (HAART) exposure in perinatally HIV-infected children was positively associated with left ventricular fractional shortening.
Synapse has enriched 10 related papers. Consider them for comparative context: